Kobay ashi S, Boggon TJ, Day aram T, et al. EGFR mutation and resistance of non- small -cell lung cancer to gefitinib. N Engl J Med 2005; 352:786 -792. PF-06936308 C3621001 Final Protocol Amendment 2, 22 Dec 2020 PFIZER CONFIDENTIAL Page 13226. Katay ama R, Shaw AT, Khan TM, et al. Mechanisms of acquired crizotinib resistance in AL K rearranged lung cancers. Sci Transl Med 2012; 4:120ra17.